Ziekenhuis Netwerk Antwerpen (ZNA) and GZA Hospitals chose Mindpeak’s PD-L1 AI to become the first lab in Belgium to use artificial intelligence in the fight against cancer.

Mindpeak scores successfully in new digital quality test (Digital Readout Test) by leading German pathology quality assurance service provider QuIP

We are very proud to announce the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest)

We are very delighted that Unilabs, the leading diagnostic services provider, has now brought our AI solutions into the clinical routine to speed up breast cancer diagnosis and make it more accurate.

We at Mindpeak GmbH are looking forward to meeting you in person again, on this year’s ECDP, June 15-18th (Germany, Berlin)! Come to our Booth (B13) at Titanic Chaussee Berlin, meet Felix Faber (CEO), Dr. Andreas Hartlep (COO) and Dr. Anil Berger (VP Sales & Marketing).

We at Mindpeak GmbH are very happy to announce the CE mark for our „Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI“, a plug-and-play AI solution to detect and quantify PD-L1 expression within user-defined Regions of Interest (RoI) on non-small-cell lung cancer.